Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody

Journal of Molecular and Cellular Cardiology

Volumn 42, Issue 4, 2007, Pages 781-791

  Gong, Xuelian ^a   Feng, Hao ^a   Zhang, Shuying ^a   Yu, Yizhi ^a   Li, Jianzhong ^a   Wang, Jvrong ^a   Guo, Baoyu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CC chemokine receptor 5; Cognate chemokine; Experimental autoimmune myocarditis; Monoclonal antibody; T cell

Indexed keywords

CHEMOKINE RECEPTOR CCR5; LIGAND; MONOCLONAL ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CELL SUSPENSION; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; MOUSE; MYOCARDITIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, SCID; MYOCARDITIS; RECEPTORS, CCR5; RNA, MESSENGER; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

MUS;

EID: 34047147818     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.02.003     Document Type: Article

References (31)

1. Maisch B., Deeg P., Liebau G., and Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am. J. Cardiol. 52 (1983) 1072-1078
2. Kodama M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., and Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 57 (1990) 250-262
3. Neu N., Rose N.R., Beisel K.W., Herskowitz A., Gurri-Glass G., and Craig S.W. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 139 (1987) 3630-3636
4. Smith S.C., and Allen P.M. The role of T cells in myosin-induced autoimmune myocarditis. Clin. Immunol. Immunopathol. 68 (1993) 100-106
5. Wang Y., Afanasyeva M., Hill S.L., and Rose N.R. Characterization of murine autoimmune myocarditis induced by self and foreign cardiac myosin. Autoimmunity 31 (1999) 151-162
6. Paskhina T.S. Studies on substances causing formation of exudates and migration of leukocytes in foci of inflammation; other than protein fractions in inflammatory exudates. Dokl. Akad. Nauk SSSR 86 (1952) 609-612
7. Goser S., Ottl R., Brodner A., Dengler T.J., Torzewski J., Egashira K., et al. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 112 (2005) 3400-3407
8. + T lymphocytes into inflamed joints of rheumatoid arthritis. Int. Immunol. 11 (1999) 553-559
9. Machado F.S., Koyama N.S., Carregaro V., Ferreira B.R., Milanezi C.M., Teixeira M.M., et al. CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J. Infect. Dis. 191 (2005) 627-636
10. Futamatsu H., Suzuki J., Kosuge H., Yokoseki O., Kamada M., Ito H., et al. Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. Cardiovasc. Res. 59 (2003) 95-104
11. Smith S.C., and Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 147 (1991) 2141-2147
12. Cook D.N., Beck M.A., Coffman T.M., Kirby S.L., Sheridan J.F., Pragnell I.B., et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269 (1995) 1583-1585
13. Liu W., Nakamura H., Shioji K., Tanito M., Oka S., Ahsan M.K., et al. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Circulation 110 (2004) 1276-1283
14. Toyozaki T., Saito T., Shiraishi H., Tsukamoto Y., Takano H., Nagai T., et al. Macrophage inflammatory protein-1alpha relates to the recruitment of inflammatory cells in myosin-induced autoimmune myocarditis in rats. Lab. Invest. 81 (2001) 929-936
15. Yuan Z., Kishimoto C., and Shioji K. Beneficial effects of low-dose benidipine in acute autoimmune myocarditis: suppressive effects on inflammatory cytokines and inducible nitric oxide synthase. Circ. J. 67 (2003) 545-550
16. Neu N., Klieber R., Fruhwirth M., and Berger P. Cardiac myosin-induced myocarditis as a model of postinfectious autoimmunity. Eur. Heart J. 12 (1991) 117-120
17. Aliberti J.C., Machado F.S., Souto J.T., Campanelli A.P., Teixeira M.M., Gazzinelli R.T., et al. beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect. Immun. 67 (1999) 4819-4826
18. Kremlev S.G., and Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J. Neuroimmunol. 162 (2005) 71-80
19. Kremlev S.G., Roberts R.L., and Palmer C. Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J. Neuroimmunol. 149 (2004) 1-9
20. Hamada Y., Takata M., Kiyoku H., Enzan H., Doi Y., and Fujimoto S. Monomethoxypolyethylene glycol-modified cardiac myosin treatment blocks the active and passive induction of experimental autoimmune myocarditis. Circ. J. 68 (2004) 149-155
21. Pummerer C.L., Grassl G., Sailer M., Bachmaier K.W., Penninger J.M., and Neu N. Cardiac myosin-induced myocarditis: target recognition by autoreactive T cells requires prior activation of cardiac interstitial cells. Lab. Invest. 74 (1996) 845-852
22. Izumi T., Suzuki K., Saeki M., Ookura Y., Hirono S., Inomata T., et al. An ultrastructural study on experimental autoimmune myocarditis with special reference to effector cells. Eur. Heart J. 16 (1995) 75-77
23. Neu N., Ploier B., and Ofner C. Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J. Immunol. 145 (1990) 4094-4100
24. Nissler K., Pohlers D., Huckel M., Simon J., Brauer R., and Kinne R.W. Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation. Ann. Rheum. Dis. 63 (2004) 1470-1477
25. + T cells in autoimmune myocarditis. J. Immunol. Methods 304 (2005) 117-125
26. Inomata T., Watanabe T., Haga M., Hirahara H., Abo T., Okura Y., et al. Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis. Jpn. Heart J. 41 (2000) 507-517
27. Okura Y., Takeda K., Honda S., Hanawa H., Watanabe H., Kodama M., et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ. Res. 82 (1998) 1035-1042
28. Okura Y., Yamamoto T., Goto S., Inomata T., Hirono S., Hanawa H., et al. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J. Mol. Cell. Cardiol. 29 (1997) 491-502
29. Braunersreuther V., Zernecke A., Steffens S., Liehn E.A., Arnaud C., Shagdarsuren E., et al. CCR5 but not CCR1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler., Thromb., Vasc. Biol. 10 (2006) [1161-01]
30. 1 cells. Tissue Antigens 54 (1999) 572-577
31. 1 lymphocytes. Nature 391 (1998) 344-345